FOR INFORMATION CONTACT:
Lori Gardner, Senior Director
Communications & Marketing
301.984.9496 ext. 226
For Immediate Release: February 9, 2012
Association of Community Cancer Centers to Collaborate with GE Healthcare to Help Accelerate Innovative Approaches to Cancer Care
ROCKVILLE, Md.—The Association of Community Cancer Centers (ACCC) announced that GE Healthcare, a unit of General Electric Company (NYSE: GE), will sponsor the annual ACCC Innovator Awards, which honor member programs that have exhibited forward-thinking strategic planning and developed pioneering programs and replicable models.
“GE’s sponsorship of the ACCC Innovator Awards will help catalyze cancer innovation in the community setting,” said ACCC President Thomas Whittaker, MD, FACP. “The commitment to helping clinicians improve care for patients with cancer is shared by ACCC and GE. ACCC Innovator Awards recognize transformational change and honor community cancer programs for their will, drive and spirit to leverage technology, improve planning and management processes, and empower their patients as well as their staffs.”
ACCC 2012 Innovator Award winners will be recognized at ACCC’s 29th National Oncology Conference in San Antonio, Tex., October 3-6, 2012. These innovators will share their creative solutions and outstanding programs with meeting attendees, and will be featured in ACCC’s print and online publications.
Last year’s ACCC Innovator Award winners developed new solutions in such areas as the strategic planning process, reducing tobacco-related illness, telepharmacy, and ways to meet the oncology-related fertility needs of cancer patients. Award winners shared the goals of improving access, quality, and cost-effectiveness of cancer care.
GE Healthcare offers a wide portfolio for oncology and a strategy that combines cellular research, medical imaging, laboratory diagnostics, biopharmaceutical manufacturing technologies, and information technology. These innovative technologies help the oncology community increase their understanding of the causes and progression of cancer and can help physicians make more personalized cancer treatment and management decisions.
Recently, GE launched a global healthymagination commitment to help deliver better care to 10 million patients by 2020 through $1 billion in dedicated R&D investment aimed at accelerating cancer treatment progress through innovation.